Lindt & Spruengli Increases Profit Despite Market Slowdown
By Nina Kienle
Chocoladefabriken Lindt & Spruengli reported an increase in profit in 2023 on continued sales growth despite a slowdown in the global chocolate market, and hiked its dividend.
The Swiss chocolatier said on Tuesday that it increased its full-year net profit by 18% to 671.4 million Swiss francs ($758.6 million) compared with the prior year, which it attributed to price increases as a result of higher raw-material prices and inflationary pressure.
Earnings before interest and taxes increased 9.2% to CHF813.1 million, with a margin that expanded to 15.6% from 15.0%.
The company confirmed its preliminary sales figures published in January, which showed sales grew 10% organically, as well as its 2024 guidance.
The group intends to raise its dividend payout to CHF1,400 a registered share--which carry voting rights--from CHF1,300 the prior year, and to CHF140 a nonvoting participation certificate from CHF130, it said.
Write to Nina Kienle at nina.kienle@wsj.com
(END) Dow Jones Newswires
March 05, 2024 02:52 ET (07:52 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?